Polymarket’s reported $20bn valuation bid tests US prediction-market rules
A reported $1bn raise would value Polymarket above $20bn, as its CFTC-registered US arm competes with rival Kalshi under regulatory scrutiny.

Polymarket is in early discussions with prospective backers over a fundraising round of roughly $1 billion that would value the prediction market operator above $20 billion, according to a Bloomberg report citing people familiar with the private talks. The figures remain unconfirmed, with the company declining to comment when approached.
If completed, the round would mark a striking escalation in the valuation attached to a sector that regulators have only recently begun to formally accommodate within US derivatives law. It would also place Polymarket within reach of Kalshi, the rival platform that reached a $22 billion valuation in May, intensifying a contest between the two firms for dominance of a market now spanning elections, sport, economics and crypto-linked contracts.
A rapid climb through successive valuations
Bloomberg’s reported figure would represent an increase of at least 33 per cent on the $15 billion valuation attached to Polymarket’s April financing round, which reportedly raised close to $1 billion and brought in investors including D.E. Shaw and G Squared. That round followed a $600 million investment from Intercontinental Exchange, confirmed by ICE on 27 March, itself built on an earlier $1 billion commitment the exchange operator made in October 2025.
ICE’s October investment was described by the company as reflecting a valuation of approximately $8 billion, though Bloomberg had separately put the figure closer to $9 billion — a discrepancy that likely reflects different valuation methodologies rather than a genuine contradiction. Under either measure, a $20 billion-plus valuation would represent more than double where Polymarket stood less than a year earlier.
Regulatory footing underpins the growth story
Central to the valuation case is Polymarket’s return to the US market through QCX LLC, trading as Polymarket US, which the Commodity Futures Trading Commission’s official registry lists as a designated contract market since 9 July 2025. The exchange has since filed rule changes with the regulator covering fee structures, liquidity programmes, surveillance protocols and trading procedures — the routine but essential groundwork for operating a CFTC-regulated venue.
That federal registration gives Polymarket a regulated onshore channel that runs alongside its existing international platform, which continues to settle trades in crypto. The dual structure allows the firm to court US institutional volume while retaining the crypto-native settlement rails that built its earlier user base — though it also leaves the platform navigating state-level challenges to federal authority over prediction markets that continue to surface across jurisdictions.
Trading volumes across the sector give some sense of the commercial stakes. Prediction market volume reached $50.6 billion in July, according to figures cited in the report, with Kalshi alone accounting for $37.7 billion of activity on its platform. The scale of that turnover — and the private capital now chasing it — underscores how quickly event-contract trading has moved from a niche crypto curiosity toward a business attracting mainstream institutional finance.
Deal remains far from finalised
No term sheet, closing date or confirmed investor list has been disclosed, and Bloomberg’s sourcing describes the discussions as preliminary. Private funding negotiations of this scale frequently shift before completion, and both the capital raised and the eventual valuation could differ from the figures currently circulating.
For now, the reported talks signal continued investor appetite for regulated prediction-market infrastructure at a moment when the CFTC’s oversight framework for such products is still being tested in practice. Whether that appetite translates into a confirmed $20 billion valuation will depend on how the negotiations, and the wider regulatory backdrop, develop in the coming weeks.


